Martin J. Landray
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 151 publications
Effectiveness of High-Dose versus Standard-Dose Influenza Vaccine against Venous Thromboembolic Events: A Post Hoc Analysis of the DANFLU-2 Trial.
Journal: European journal of preventive cardiology
Published: July 31, 2026
Predictive Value of Urine Tubular Biomarkers on Kidney Outcomes: Observations from EMPA-KIDNEY.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: May 15, 2026
Effects of Sacubitril/Valsartan versus Irbesartan on Urine Tubular Biomarkers in Chronic Kidney Disease: Findings from the UK HARP-III Trial.
Journal: American journal of nephrology
Published: January 26, 2026
HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics.
Journal: American heart journal
Published: January 25, 2026
Positive predictive value of respiratory infection diagnoses in the Danish National Patient Registry: A post hoc validation analysis of the DANFLU-1 trial.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 13, 2026
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: January 12, 2026
A Bayesian re-analysis of the DANFLU-1 trial.
Journal: Human vaccines & immunotherapeutics
Published: January 08, 2026
Characteristics of interventional clinical trials registered in ClinicalTrials.gov, 2018-2023.
Journal: Journal of clinical and translational science
Published: September 24, 2025
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.
Journal: The New England journal of medicine
Published: September 01, 2025
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: A Prespecified Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.
Journal: JAMA cardiology
Published: August 30, 2025
High-Dose Versus Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 Trial.
Journal: Circulation. Heart failure
Published: August 30, 2025
Risk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza Vaccine: A Prespecified Secondary Analysis of the Randomized DANFLU-2 Trial.
Journal: JAMA network open
Published: August 30, 2025
Last Updated: 09/26/2026